Clinical Trial Update: A Study to Evaluate ARD-501 in Patients With Autism Spectrum Disorder [Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 2 study evaluating ARD-501 in patients with autism spectrum disorder. The sponsor is Aardvark Thera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• ARD-501

Snippet

Sponsor: Aardvark Therapeutics, Inc. | Conditions: Autism Spectrum Disorder | Phase 2 | Status: COMPLETED